Publication | Closed Access
Cancer-Related Fatigue and Circulating Biomarkers in Breast Cancer Survivors
12
Citations
46
References
2023
Year
Breast OncologyCirculating BiomarkersImmunologyImmune RegulationPathologyImmune SystemResults NlrInflammationBiomarker (Medicine)Tumor ImmunityInflammatory MarkerBlood MarkersCancer ResearchMedicineChronic InflammationImmune SurveillanceImmune FunctionInflammatory DiseasePurpose Cancer-related FatiguePrognostic BiomarkersBiomarkersBreast CancerOncology
Purpose Cancer-related fatigue (CRF) is the most common and disruptive symptom experienced by cancer survivors and because of its frequency and severity is especially worrisome in breast cancer survivors (BCS). Despite a great deal of research, the mechanisms underlying CRF have not been determined. The present study aims to describe associations between CRF in BCS and different blood biomarkers. Methods A descriptive and cross-sectional study was conducted. A set of biomarkers assessing inflammation were measured in BCS: C-reactive protein (CRP), neutrophil-lymphocyte ratio (NLR), IL-1β, IL-6, IL-8, IL-10, tumor necrosis factor (TNF); HPA axis dysfunction (cortisol), autonomic dysfunction (noradrenaline); oxidative stress (8-OH deoxyguanosine); insulin resistance markers (insulin, IGF-I, IGFBP3) and sexual hormones (estrogens, progesterone, testosterone). Results NLR ( p = .00) and cortisol ( p = .02) were positive and negatively associated with CRF, respectively. The rest of the blood markers were not associated with CRF. Conclusion Our results increase the evidence on pathophysiological mechanisms driving CRF in BCS. However, longitudinal studies are needed to explore the role of these factors as potential causal mechanisms.
| Year | Citations | |
|---|---|---|
Page 1
Page 1